Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,670 | -37,776 | -2,510 | -4,420 | -28,490 |
| Depreciation Amortization | 368 | 383 | 50 | 70 | 40 |
| Accounts payable and accrued liabilities | 121 | -1,354 | N/A | N/A | N/A |
| Other Working Capital | 143,386 | 4,907 | 730 | 1,310 | 1,700 |
| Other Operating Activity | 27 | 1,271 | 1,550 | 2,930 | 27,010 |
| Operating Cash Flow | $113,232 | $-32,569 | $-180 | $-110 | $260 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,818 | -32,726 | N/A | N/A | N/A |
| PPE Investments | -463 | -156 | -3 | -3 | -10 |
| Other Investing Activity | 0 | 0 | -187 | -77 | -430 |
| Investing Cash Flow | $-19,281 | $-32,882 | $-190 | $-80 | $-440 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 321 | 54,803 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 370 | 190 | 160 |
| Financing Cash Flow | $321 | $54,803 | $370 | $190 | $160 |
| Beginning Cash Position | 1,379 | 12,027 | 1 | 2 | 10 |
| End Cash Position | 95,651 | 1,379 | 0 | 0 | 2 |
| Net Cash Flow | $94,272 | $-10,648 | $-1 | $-2 | $-10 |
| Free Cash Flow | |||||
| Operating Cash Flow | 113,232 | -32,569 | -180 | -110 | 260 |
| Capital Expenditure | -463 | -156 | N/A | N/A | N/A |
| Free Cash Flow | 112,769 | -32,725 | -180 | -110 | 260 |